308 related articles for article (PubMed ID: 23560587)
21. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
Varettoni M; Arcaini L; Zibellini S; Boveri E; Rattotti S; Riboni R; Corso A; Orlandi E; Bonfichi M; Gotti M; Pascutto C; Mangiacavalli S; Croci G; Fiaccadori V; Morello L; Guerrera ML; Paulli M; Cazzola M
Blood; 2013 Mar; 121(13):2522-8. PubMed ID: 23355535
[TBL] [Abstract][Full Text] [Related]
22. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Manasanch EE; Braylan R; Stetler-Stevenson M; Yuan C; Gounden V; Korde N; Tageja N; Bhutani M; Calvo K; Maric I; Roschewski M; Staudt LM; Landgren O
Leuk Lymphoma; 2014 Jun; 55(6):1402-3. PubMed ID: 23915224
[No Abstract] [Full Text] [Related]
23. Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Talaulikar D; Joshua D; Ho PJ; Gibson J; Quach H; Gibbs S; Ling S; Ward C; Augustson BM; Trotman J; Harrison SJ; Tam CS;
Intern Med J; 2023 Apr; 53(4):599-609. PubMed ID: 36441109
[TBL] [Abstract][Full Text] [Related]
24. IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Minervini CF; Brunetti C; Impera L; Ricco A; Cellamare A; Specchia G; Albano F
Ann Hematol; 2014 Sep; 93(9):1605-7. PubMed ID: 24408161
[No Abstract] [Full Text] [Related]
25. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.
Jiménez C; Chillón Mdel C; Balanzategui A; Puig N; Sebastián E; Alcoceba M; Sarasquete ME; Conde IP; Corral R; Marín LA; Paiva B; Ruano M; Antón A; Maldonado R; San Miguel JF; González M; García-Sanz R
Appl Immunohistochem Mol Morphol; 2014; 22(10):768-73. PubMed ID: 24992174
[TBL] [Abstract][Full Text] [Related]
26. The MYD88
Kapoor P
Br J Haematol; 2019 Nov; 187(4):413-415. PubMed ID: 31298748
[No Abstract] [Full Text] [Related]
27. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T
Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445
[TBL] [Abstract][Full Text] [Related]
28. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
[TBL] [Abstract][Full Text] [Related]
29. MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Poulain S; Boyle EM; Roumier C; Demarquette H; Wemeau M; Geffroy S; Herbaux C; Bertrand E; Hivert B; Terriou L; Verrier A; Pollet JP; Maurage CA; Onraed B; Morschhauser F; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Br J Haematol; 2014 Nov; 167(4):506-13. PubMed ID: 25160558
[TBL] [Abstract][Full Text] [Related]
30. IgM Plasma Cell Myeloma.
Lu H; Durkin L; Zhao X; Nakashima MO
Am J Clin Pathol; 2022 Jan; 157(1):47-53. PubMed ID: 34508562
[TBL] [Abstract][Full Text] [Related]
31.
Yu X; Li W; Deng Q; Li L; Hsi ED; Young KH; Zhang M; Li Y
Cancer Res; 2018 May; 78(10):2457-2462. PubMed ID: 29703722
[TBL] [Abstract][Full Text] [Related]
32. Detection of the MYD88
Wu YY; Jia MN; Cai H; Qiu Y; Zhou DB; Li J; Cao XX
Ann Hematol; 2020 Aug; 99(8):1763-1769. PubMed ID: 32577844
[TBL] [Abstract][Full Text] [Related]
33. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract][Full Text] [Related]
34. MYD88 L265P somatic mutation in IgM MGUS.
Landgren O; Staudt L
N Engl J Med; 2012 Dec; 367(23):2255-6; author reply 2256-7. PubMed ID: 23215570
[No Abstract] [Full Text] [Related]
35. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.
Wang W; Lin P
Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130
[TBL] [Abstract][Full Text] [Related]
36. MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.
Gustine JN; Meid K; Hunter ZR; Xu L; Treon SP; Castillo JJ
Br J Haematol; 2018 Feb; 180(4):578-581. PubMed ID: 27748515
[No Abstract] [Full Text] [Related]
37. [The use of electrochromatographic separation of serum proteins in the diagnosis of myeloma and macroglobulinaemia IGM (author's transl)].
Blicharski J; Bobrzecka K; Konieczny L; Laidler P; Rybarska J; Wazewska-Czyzewska M
Przegl Lek; 1980; 37(3):345-9. PubMed ID: 6769138
[No Abstract] [Full Text] [Related]
38. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.
Treon SP; Cao Y; Xu L; Yang G; Liu X; Hunter ZR
Blood; 2014 May; 123(18):2791-6. PubMed ID: 24553177
[TBL] [Abstract][Full Text] [Related]
40. MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia.
Kim JA; Im K; Park SN; Kwon J; Choi Q; Hwang SM; Sekiguchi N; Yoon SS; Lee DS; Kim SY
Biomed Res Int; 2014; 2014():363540. PubMed ID: 24895570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
